In vitro nephron models can play a vital part in the accurate assessment of drug- induced toxicity and disease modelling to better understand kidney diseases and develop more effective treatments. The glomerulus is a critical part of the kidney, responsible for filtering blood and creating urine. Gaining access to a highly accurate and functional glomerulus model that closely mimics the structure and function of the human kidney has the potential to revolutionise drug discovery and development. Learn more about our glomerulus model developed with our advanced technology and expertise: https://lnkd.in/evCkbdB2 #NewcellsBiotech #Kidney #DrugDiscovery #Innovation #Biotechnology
Newcells Biotech Ltd’s Post
More Relevant Posts
-
🔎 Want to learn more about Microvesicles? What are their clinical interests? Listen to Prof. françoise dignat-george and Dr. romaric lacroix speak about Microparticles (MVs) as an emerging biomarker with multifaced clinical indications. 👉 https://lnkd.in/e5aynjtE MVs have been described as procoagulant entities since their first report due to the presence of negative procoagulant phospholipids – mainly phosphatidylserine – and/or tissue factor at their surface. Learn more 👉 https://lnkd.in/d5cGvir7 #microvesicles #diagnosis #clinical #clinicalstudies #thrombosis #webinar #educational
To view or add a comment, sign in
-
How can ultrasound waves treat Parkinson’s disease? Our recent webinar covered new trends like antibody-drug conjugates, CRISPR drugs, and more, featuring experts from national labs, Ohio State, and more. View the recording to learn more about emerging trends to watch: https://ow.ly/Twk550QBbkU
To view or add a comment, sign in
-
🔎 Want to learn more about Microvesicles? What are their clinical interest? Listen to Prof. françoise dignat-george and Dr. romaric lacroix speak about Microparticles (MVs) as an emerging biomarker with multifaced clinical indications. 👉 https://lnkd.in/e5aynjtE MVs have been described as procoagulant entities since their first report due to the presence of negative procoagulant phospholipids – mainly phosphatidylserine – and/or tissue factor at their surface. Learn more 👉 https://lnkd.in/e6M6E5r8 #microvesicles #diagnosis #clinical #clinicalstudies #thrombosis #webinar #educational
To view or add a comment, sign in
-
Introducing Huma NephroMatrix Coat, kidney ECM derived from nutrient-rich human kidney tissue maintaining native matrix proteins and growth factors providing a highly relevant environment for advanced cell culture applications. Huma NephroMatrix is ideal for in-vitro kidney models, renal disease studies, and #tissueengineering. It enables accurate disease modeling and aids in therapeutic development. Be a part of the future in kidney research and #regenerativemedicine with clinically relevant, affordable, and supply stable #biomaterials. Learn more about Huma NephroMatrix Coat here: https://lnkd.in/gjV7xkyE #cellculture #biomedical #drugdiscovery #cancerresearch
To view or add a comment, sign in
-
New 3i Investigator Article Alert!! Effect of benralizumab on histopathology and inflammatory signatures in a clinical cohort of eosinophilic esophagitis https://lnkd.in/gPPXi9u7
To view or add a comment, sign in
-
𝐈𝐧𝐟𝐥𝐚𝐦𝐦𝐚𝐭𝐨𝐫𝐲 / 𝐀𝐧𝐭𝐢-𝐈𝐧𝐟𝐥𝐚𝐦𝐦𝐚𝐭𝐨𝐫𝐲 𝐏𝐚𝐧𝐞𝐥 𝐟𝐨𝐫 𝐅𝐨𝐜𝐮𝐬𝐞𝐝 𝐁𝐢𝐨𝐦𝐚𝐫𝐤𝐞𝐫 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲: with this target panel, Sapient assays key small molecules known to exhibit pro- or anti-inflammatory properties. Subtle changes in these #metabolite and #lipid profiles can signal inflammation at early timepoints and elucidate mechanisms underlying #inflammatory processes, as well as help to evaluate the effects of anti-inflammatory treatments. Learn more about the panel and how to order here: https://lnkd.in/gyR3vC3q #inflammatoryprofiling #targetedmetabolomics
To view or add a comment, sign in
-
Efficacy and safety of recombinant ADAMTS13, administered as routine prophylaxis in patients with congenital TTP, were assessed in this phase 3, open-label, crossover trial. Conclusions were as follows: ADAMTS13 activity reached approximately 100% of normal levels, adverse events were generally mild or moderate in severity, and TTP events and manifestations were rare. https://lnkd.in/evhZXM4Q
Recombinant ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura | NEJM
nejm.org
To view or add a comment, sign in
-
✅️ The Potential of Precision Medicine: Tailoring Healthcare for Every Individual! From genetic testing to targeted therapies, discover how this innovative approach is transforming the way we diagnose and treat medical conditions. Join us on LinkedIn to discover the impacts and applications of precision medicine. Visit More : https://lnkd.in/gvT_Vv8t #healthcare #medicine #pharmacogenomics #drugdevelopment
To view or add a comment, sign in
-
🔬🧬 Discover the Future of Medicine with OneDrug! 🧬🔬 Explore how pharmacogenetics revolutionises healthcare by predicting adverse drug reactions (ADRs) and personalizing treatments. From genetic testing to advanced clinical applications, learn how OneDrug is paving the way for safer, more effective therapies. Join us on this journey towards personalized medicine! 🚀💊 #Pharmacogenetics #PersonalizedMedicine #OneDrug #HealthcareInnovation #MedicalResearch Read the article here: Frontiers | Role of Pharmacogenetics in Adverse Drug Reactions: An Update towards Personalized Medicine (frontiersin.org)
To view or add a comment, sign in
3,876 followers
More from this author
-
The Intensity of Innovation: Insights from the Japanese Society of Toxicology Conference
Newcells Biotech Ltd 1mo -
How does Newcells work with their clients? Listen to our CEO, Dr Mike Nicholds explaining.
Newcells Biotech Ltd 2mo -
Dr Mike Nicholds, CEO talks about the inspiration and drive behind the company and the mission to improve in vitro to clinical translation
Newcells Biotech Ltd 6mo